WindMIL Therapeutics

About:

WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients.

Website: https://windmiltx.com

Top Investors: Qiming Venture Partners, FoxKiser, Domain Associates, Camden Partners, Medivate Partners

Description:

WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients. The company leveraging its proprietary platform to develop a novel class of cell therapies called MILs (Marrow Infiltrating Lymphocytes) derived from memory T cells found in the bone marrow. WindMIL Therapeutics was established in 2015 and is based in Baltimore, MD.